"Trust Issues and Hot Trends: Key Takeaways from JPMorgan Healthcare Conference 2024"
At the J.P. Morgan Healthcare Conference, Recursion, a biotech firm using AI for drug development, made a splash with AI-driven drug discovery software in collaboration with Nvidia, as the tech giant's stock soars due to AI expectations. The event showcased AI's potential, but skepticism remains as not everyone is ready to embrace its impact on healthcare.